MedTrace Logo

Shanghai Clinical Cohort - Adrenal Disease

NCT07191951 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2025-11-17

No results posted yet for this study

Summary

As a vital organ responsible for producing life-sustaining hormones, the adrenal gland is associated with a wide range of diseases. These diseases affect multiple systems throughout the body and carry a high rate of mortality and disability. Current diagnosis and treatment face several challenges: significant variability in hormone testing results, inaccurate localization via imaging techniques, unclear molecular characteristics of adrenal tumors, and difficulty in determining prognosis through pathology. Therefore, establishing a clinical research cohort for adrenal diseases is essential. Such a cohort will enable in-depth exploration of disease mechanisms, identification of disease subtypes, optimization of diagnostic criteria, evaluation of treatment efficacy, advancement of personalized medicine, and formulation of prevention and treatment strategies.

Conditions

  • Adrenal Disease

Interventions

OTHER

Receive adrenal surgery, radiotherapy, and/or medication therapy based on diagnosis and subtype classification.

Receive adrenal surgery, radiotherapy, and/or medication therapy based on diagnosis and subtype classification.

Sponsors & Collaborators

  • Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

    collaborator UNKNOWN

  • RenJi Hospital

    collaborator OTHER

  • Shanghai Zhongshan Hospital

    collaborator OTHER

  • Shanghai Public Health Clinical Center

    collaborator OTHER_GOV

  • Shanghai Jiao Tong University School of Medicine

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-25
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07191951 on ClinicalTrials.gov